
IRAK-1-4 Inhibitor I
CAS No. 509093-47-4
IRAK-1-4 Inhibitor I( IRAK-1/4 Inhibitor I )
Catalog No. M14746 CAS No. 509093-47-4
IRAK-1-4 Inhibitor I is a potent, dual inhibitor of IRAK4 and IRAK1 with IC50 of 0.2 uM and 0.3 uM, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 45 | In Stock |
![]() ![]() |
5MG | 65 | In Stock |
![]() ![]() |
10MG | 101 | In Stock |
![]() ![]() |
25MG | 232 | In Stock |
![]() ![]() |
50MG | 437 | In Stock |
![]() ![]() |
100MG | 626 | In Stock |
![]() ![]() |
500MG | 1341 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameIRAK-1-4 Inhibitor I
-
NoteResearch use only, not for human use.
-
Brief DescriptionIRAK-1-4 Inhibitor I is a potent, dual inhibitor of IRAK4 and IRAK1 with IC50 of 0.2 uM and 0.3 uM, respectively.
-
DescriptionIRAK-1-4 Inhibitor I is a potent, dual inhibitor of IRAK4 and IRAK1 with IC50 of 0.2 uM and 0.3 uM, respectively; displays IC50 of >10 uM against a panel of 27 other kinases, including the most closely homologous (outside of the IRAK family) Lck and pp60SRC; eliminates the LPS-induced increases in Bcl10, NF-κB, and IL-8 in human intestinal epithelial cells.
-
In Vitro——
-
In Vivo——
-
SynonymsIRAK-1/4 Inhibitor I
-
PathwayImmunology/Inflammation
-
TargetIRAK
-
RecptorIRAK-1|IRAK-4
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number509093-47-4
-
Formula Weight395.4
-
Molecular FormulaC20H21N5O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NC1=NC2=CC=CC=C2N1CCN3CCOCC3)C4=CC=CC([N+]([O-])=O)=C4
-
Chemical NameBenzamide, N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitro-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Powers JP, et al. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2842-5.
2. Bhattacharyya S, et al. Am J Physiol Gastrointest Liver Physiol. 2007 Aug;293(2):G429-37.
molnova catalog



related products
-
IRAK-1-4 Inhibitor I
IRAK-1-4 Inhibitor I is a potent, dual inhibitor of IRAK4 and IRAK1 with IC50 of 0.2 uM and 0.3 uM, respectively.
-
Zabedosertib
Zabedosertib (BAY 1834845) is an inhibitor of IRAK4 with immunomodulatory potential. Zabedosertib protects against acute respiratory distress syndrome, a new study suggests.
-
PF-06650833
PF-06650833 (PF06650833) is a potent and selective IRAK4 inhibitor with IC50 of 0.2 nM.